Pacira BioSciences, Inc (PCRX) insider trading
Every open-market stock purchase and sale by Pacira BioSciences, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Lauren Riker (President) and 1 other sold $289K in the last 90 days.
- Last insider buy: Marcelo Bigal (Director), $20K, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $2.8M (14 sales). Last close $36.33 on Oct 21, 2026.
Recent PCRX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 8, 2026 | Lauren Riker (President) | Sold | $218K |
| Oct 8, 2026 | Lauren Riker (President) | Bought (not open market) | $194K |
| Oct 8, 2026 | Lauren Riker (President) | Bought (not open market) | — |
| Aug 17, 2026 | Jonathan Slonin (C-suite exec) | Sold | $70.6K |
| Jun 11, 2026 | Lauren Riker (President) | Sold | $144K |
| Jun 10, 2026 | Christopher Christie (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Christopher Christie (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Mark Froimson (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Mark Froimson (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Samit Hirawat (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Samit Hirawat (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Michael J. Yang (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Alethia Young (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Alethia Young (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Thomas G Wiggans (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Michael J. Yang (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Marcelo Bigal (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Marcelo Bigal (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Laura Brege (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Laura Brege (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Kristen Williams (C-suite exec) | Sold | $228K |
| Jun 3, 2026 | Kristen Williams (C-suite exec) | Sold (not open market) | $190K |
| Jun 3, 2026 | Jonathan Slonin (C-suite exec) | Sold (not open market) | $106K |
| Jun 3, 2026 | Lauren Riker (President) | Sold (not open market) | $71.1K |
| Apr 23, 2026 | Shawn Cross (CFO) | Sold | $326K |
Who's trading PCRX
- Lauren Riker, President: sold $479K (4 sales), last Oct 8, 2026
- Jonathan Slonin, C-suite exec: sold $240K (3 sales), last Aug 17, 2026
- Christopher Christie, Director: other filings, last Jun 10, 2026
- Mark Froimson, Director: sold $10.9K (1 sale), last Jun 10, 2026
- Marcelo Bigal, Director: other filings, last Jun 10, 2026
- Laura Brege, Director: other filings, last Jun 10, 2026
- Samit Hirawat, Director: other filings, last Jun 10, 2026
- Thomas G Wiggans, Director: other filings, last Jun 10, 2026
- Michael J. Yang, Director: other filings, last Jun 10, 2026
- Alethia Young, Director: other filings, last Jun 10, 2026
- Kristen Williams, C-suite exec: sold $498K (2 sales), last Jun 4, 2026
- Shawn Cross, CFO: sold $1.5M (7 sales), last Apr 23, 2026
- Frank D. Lee, CEO: other filings, last Feb 11, 2026
- Brendan Teehan, C-suite exec: other filings, last Feb 11, 2026
Get free alerts when an insider at Pacira BioSciences, Inc files a new trade →